Aggregated Albumin (RADPHARM MAA kit for the production of Technetium (99mTc) Macrosalb powder for injection multidose vial)
What to know about Aggregated Albumin — also sold as RADPHARM MAA kit for the production of Technetium (99mTc) Macrosalb powder for injection multidose vial: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Aggregated Albumin (brand names: RADPHARM MAA kit for the production of Technetium (99mTc) Macrosalb powder for injection multidose vial) is classified as Minimal risk by AllMeds. It is a S4 medication under the TGA in Australia. Diagnostic radiopharmaceutical with no workplace safety risk.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Minimal (0 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | Not PBS listed |
Risk Profile
Diagnostic radiopharmaceutical with no workplace safety risk.
How Aggregated Albumin is regulated
Aggregated Albumin is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Check this medication against your full medication list
Run a full risk assessment including Aggregated Albumin interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.